{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:12:39Z","timestamp":1790482359150,"version":"4.1.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T00:00:00Z","timestamp":1534204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T00:00:00Z","timestamp":1534204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA166672"],"award-info":[{"award-number":["R01 CA166672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24 AR069760"],"award-info":[{"award-number":["K24 AR069760"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA098838"],"award-info":[{"award-number":["R01 CA098838"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1111\/bjd.16713","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T19:23:21Z","timestamp":1525375401000},"page":"1088-1094","source":"Crossref","is-referenced-by-count":42,"title":["Photosensitizing antihypertensive drug use and risk of cutaneous squamous cell carcinoma"],"prefix":"10.1093","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2743-2079","authenticated-orcid":false,"given":"K.A.","family":"Su","sequence":"first","affiliation":[{"name":"Department of Dermatology; Massachusetts General Hospital; Boston MA U.S.A."},{"name":"Department of Population Medicine; Harvard Pilgrim Health Care Institute, Harvard Medical School; Boston MA U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Habel","sequence":"additional","affiliation":[{"name":"Division of Research; Kaiser Permanente Northern California; Oakland CA U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.S.","family":"Achacoso","sequence":"additional","affiliation":[{"name":"Division of Research; Kaiser Permanente Northern California; Oakland CA U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.D.","family":"Friedman","sequence":"additional","affiliation":[{"name":"Division of Research; Kaiser Permanente Northern California; Oakland CA U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Asgari","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Massachusetts General Hospital; Boston MA U.S.A."},{"name":"Department of Population Medicine; Harvard Pilgrim Health Care Institute, Harvard Medical School; Boston MA U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,14]]},"reference":[{"key":"10.1111\/bjd.16713-BIB0001|bjd16713-cit-0001","unstructured":"Levine JI Medications that increase sensitivity to light: a 1990 listing. US Department of Health and Human Services http:\/\/www.nj.gov\/health\/ceohs\/documents\/phss\/fda_photosensitivitylist.pdf"},{"key":"10.1111\/bjd.16713-BIB0002|bjd16713-cit-0002","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2165\/11592780-000000000-00000","article-title":"Drug-induced photosensitivity: culprit drugs, management and prevention","volume":"34","author":"Drucker","year":"2011","journal-title":"Drug Saf"},{"key":"10.1111\/bjd.16713-BIB0003|bjd16713-cit-0003","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00045415-200207000-00008","article-title":"Adverse dermatologic effects of cardiovascular drug therapy: part I","volume":"10","author":"Frishman","year":"2002","journal-title":"Cardiol Rev"},{"key":"10.1111\/bjd.16713-BIB0004|bjd16713-cit-0004","first-page":"27","article-title":"Mechanisms of photosensitization induced by drugs: a general survey","volume":"41","author":"Quintero","year":"2000","journal-title":"Ars Pharm"},{"key":"10.1111\/bjd.16713-BIB0005|bjd16713-cit-0005","unstructured":"Elias J Fernandez G Guidance on minimising photosensitivity\/phototoxicity reactions between medication and sunlight"},{"key":"10.1111\/bjd.16713-BIB0006|bjd16713-cit-0006","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0190-9622(95)91271-1","article-title":"Cutaneous photosensitivity diseases induced by exogenous agents","volume":"33","author":"Gould","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16713-BIB0007|bjd16713-cit-0007","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00002018-200225050-00004","article-title":"Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management","volume":"25","author":"Moore","year":"2002","journal-title":"Drug Saf"},{"key":"10.1111\/bjd.16713-BIB0008|bjd16713-cit-0008","first-page":"55","article-title":"Drug-induced photosensitivity","volume":"24","author":"Zuba","year":"2016","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1111\/bjd.16713-BIB0009|bjd16713-cit-0009","unstructured":"US Department of Health and Human Services S10 photosafety evaluation of pharmaceuticals: guidance for industry https:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm337572.pdf"},{"key":"10.1111\/bjd.16713-BIB0010|bjd16713-cit-0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/phpp.12085","article-title":"Photosensitizing medications and photocarcinogenesis","volume":"30","author":"O'Gorman","year":"2014","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/bjd.16713-BIB0011|bjd16713-cit-0011","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrc3611","article-title":"Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms","volume":"13","author":"Elinav","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1111\/bjd.16713-BIB0012|bjd16713-cit-0012","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0378-4274(98)00237-9","article-title":"Photocarcinogenicity of drugs","volume":"102-103","author":"Stern","year":"1998","journal-title":"Toxicol Lett"},{"key":"10.1111\/bjd.16713-BIB0013|bjd16713-cit-0013","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archdermatol.2010.19","article-title":"Incidence estimate of nonmelanoma skin cancer in the United States, 2006","volume":"146","author":"Rogers","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.16713-BIB0014|bjd16713-cit-0014","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/archinternmed.2012.2754","article-title":"Antihypertensive drugs and lip cancer in non-Hispanic whites","volume":"172","author":"Friedman","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1111\/bjd.16713-BIB0015|bjd16713-cit-0015","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/joim.12629","article-title":"Hydrochlorothiazide use is strongly associated with risk of lip cancer","volume":"282","author":"Potteg\u00e5rd","year":"2017","journal-title":"J Intern Med"},{"key":"10.1111\/bjd.16713-BIB0016|bjd16713-cit-0016","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jaad.2017.11.042","article-title":"Hydrochlorothiazide use and risk of non-melanoma skin cancer: a nationwide case-control study from Denmark","volume":"78","author":"Pedersen","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16713-BIB0017|bjd16713-cit-0017","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/jnci\/djn262","article-title":"Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial","volume":"100","author":"Christian","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl. 2","key":"10.1111\/bjd.16713-BIB0018|bjd16713-cit-0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2012.11081.x","article-title":"Known and potential new risk factors for skin cancer in European populations: a multicentre case-control study","volume":"167","author":"Vries","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16713-BIB0019|bjd16713-cit-0019","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/sj.bjc.6604686","article-title":"Use of photosensitising diuretics and risk of skin cancer: a population-based case-control study","volume":"99","author":"Jensen","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1111\/bjd.16713-BIB0020|bjd16713-cit-0020","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1158\/1055-9965.EPI-10-0652","article-title":"Photosensitizing medication use and risk of skin cancer","volume":"19","author":"Kaae","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/bjd.16713-BIB0021|bjd16713-cit-0021","doi-asserted-by":"crossref","first-page":"439","DOI":"10.5414\/CNP73439","article-title":"Keratinocyte cancer prevention with ACE inhibitors, angiotensin receptor blockers or their combination in renal transplant recipients","volume":"73","author":"Moscarelli","year":"2010","journal-title":"Clin Nephrol"},{"key":"10.1111\/bjd.16713-BIB0022|bjd16713-cit-0022","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40264-016-0487-9","article-title":"Melanoma and non-melanoma skin cancer associated with angiotensin-converting-enzyme inhibitors, angiotensin-receptor blockers and thiazides: a matched cohort study","volume":"40","author":"Nardone","year":"2017","journal-title":"Drug Saf"},{"key":"10.1111\/bjd.16713-BIB0023|bjd16713-cit-0023","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/jid.2013.33","article-title":"Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study","volume":"133","author":"Robinson","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16713-BIB0024|bjd16713-cit-0024","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/jdv.12921","article-title":"Use of antihypertensive drugs and risk of skin cancer","volume":"29","author":"Schmidt","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.16713-BIB0025|bjd16713-cit-0025","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jid.2016.01.013","article-title":"Identification of susceptibility loci for cutaneous squamous cell carcinoma","volume":"136","author":"Asgari","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16713-BIB0026|bjd16713-cit-0026","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jclinepi.2008.01.006","article-title":"The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients","volume":"61","author":"Charlson","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/bjd.16713-BIB0027|bjd16713-cit-0027","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/pds.4384","article-title":"Use of antihypertensive drugs and risk of keratinocyte carcinoma: a meta-analysis of observational studies","volume":"27","author":"Tang","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/bjd.16713-BIB0028|bjd16713-cit-0028","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0140-6736(09)61196-X","article-title":"Non-melanoma skin cancer","volume":"375","author":"Madan","year":"2010","journal-title":"Lancet"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.16713","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.16713\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T08:41:21Z","timestamp":1676364081000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/179\/5\/1088\/6732575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,14]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.16713","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8,14]]}}}